Secured Note Purchase Agreement Sample Contracts

This Secured Note Purchase Agreement (this “Agreement”), dated as of May 15, 2023, is entered into among JIMMY JANG, L.P., a Delaware limited partnership (“Jimmy Jang”), BAKER TECHNOLOGIES, INC., a Delaware corporation (“Baker”), COMMONWEALTH ALTERNATIVE CARE, INC., a Massachusetts corporation (“CAC”), JUPITER RESEARCH, LLC, an Arizona limited liability company (“Jupiter”), and each of the undersigned parties executing this agreement as a Borrower (collectively, with their respective successors and assigns, and together with Jimmy Jang, Baker, CAC and Jupiter, collectively, the “Borrowers” and each a “Borrower”), TILT HOLDINGS INC., a British Columbia corporation (the “Parent”), JORDAN GEOTAS, as noteholder representative (the “Noteholder Representative”) on behalf of the purchasers (each, individually a “Purchaser,” and collectively, the “Purchasers”) named on the Schedule of Purchasers attached hereto as Schedule 1 (the “Schedule of Purchasers”). For greater certainty, the term “Purc

Secured Note Purchase Agreement • August 22nd, 2003 • Euniverse Inc • Retail-record & prerecorded tape stores • California

This Secured Note Purchase Agreement (the “Agreement”) is made this 15th day of July, 2003 (the “Effective Date”) by and between eUniverse, Inc., a Delaware corporation (the “Company”), and VP Alpha Holdings IV, L.L.C. (the “Purchaser”).

Secured Note Purchase Agreement • May 15th, 2024 • HCW Biologics Inc. • Pharmaceutical preparations • New York

This Senior Secured Note Purchase Agreement (this “Agreement”) is made as of March 28, 2024 (the “Closing Date”) by and between HCW Biologics Inc., a Delaware corporation (the “Company”), and each of the purchasers listed on Exhibit B attached to this Agreement (each a “Purchaser” and together the “Purchasers”).

If iPsatank-eAnralybaicnodrinbtaricctaetreiolyid, hPohwinteharsasuhsiunaglliys cToauitnet?erOfefift-Bhrisoagdawlvaaynoamndetdryecwuhpilpe-tZaeileddeksiawhithinotrrebnlcuhr, but

Secured Note Purchase Agreement • June 15th, 2007 • Medicalcv Inc • Surgical & medical instruments & apparatus • Minnesota

THIS SECURED NOTE PURCHASE AGREEMENT (the “Agreement”) is entered into effective as of the 15th day of June, 2007 (the “Effective Date”), by and among MedicalCV, Inc., a Minnesota corporation (the “Company”) and the holders listed under “Second Closing” on Schedule 1.0 hereto (each a “Holder” and collectively the “Holders”), as part of the second closing of the 2007 Secured Notes.

Secured Note Purchase Agreement • April 20th, 2007 • Medicalcv Inc • Surgical & medical instruments & apparatus • Minnesota

THIS SECURED NOTE PURCHASE AGREEMENT (the “Agreement”) is entered into effective as of the 20th day of April, 2007 (the “Effective Date”), by and among MedicalCV, Inc., a Minnesota corporation (the “Company”), and the holders listed on Schedule 1.0 hereto (each a “Holder” and collectively the “Holders”).

Secured Note Purchase Agreement • May 9th, 2012 • Encore Capital Group Inc • Short-term business credit institutions • New York

THIS AMENDMENT NO. 1 (“Amendment”) is made as of May 8, 2012 by and among Encore Capital Group, Inc. (the “Company”), the undersigned holders of Notes (the “Noteholders”) and, solely for purpose of Section 1 of this Amendment, SunTrust Bank (“SunTrust”), as, on and after the Amendment No. 1 Effective Date, collateral agent (the “Collateral Agent”) under that certain Intercreditor Agreement, dated as of September 20, 2010, by and among the Noteholders and JPMorgan Chase Bank, N.A. (“JPMorgan”), as, prior to the Amendment No. 1 Effective Date, collateral agent and administrative agent thereunder and, for purpose of certain provisions thereof, the Company and the other Credit Parties (as amended, supplemented or otherwise modified from time to time, the “Intercreditor Agreement”). Reference is made to that certain Amended and Restated Senior Secured Note Purchase Agreement, dated as of February 10, 2011, between the Company, on the one hand, and the Purchasers named therein, on the other

Secured Note Purchase Agreement • September 30th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York